Studying Parkinson's disease using Caenorhabditis elegans models in microfluidic devices

K Youssef, A Tandon, P Rezai - Integrative Biology, 2019 - academic.oup.com
Parkinson's disease (PD) is a progressive neurological disorder associated with the loss of
dopaminergic neurons (DNs) in the substantia nigra and the widespread accumulation of α …

Using a Caenorhabditis elegans Parkinson's Disease Model to Assess Disease Progression and Therapy Efficiency

S Hughes, M van Dop, N Kolsters, D van de Klashorst… - Pharmaceuticals, 2022 - mdpi.com
Despite Parkinson's Disease (PD) being the second most common neurodegenerative
disease, treatment options are limited. Consequently, there is an urgent need to identify and …

Microfluidics for the analysis of behavior, nerve regeneration, and neural cell biology in C. elegans

A Ben-Yakar, N Chronis, H Lu - Current opinion in neurobiology, 2009 - Elsevier
The nematode Caenorhabditis elegans is a widely adopted model organism for studying
various neurobiological processes at the molecular and cellular level in vivo. With a small …

Traversing a wormhole to combat Parkinson's disease

GA Caldwell, KA Caldwell - Disease models & mechanisms, 2008 - journals.biologists.com
Human movement disorders represent a significant and unresolved societal burden. Among
these, the most prevalent is Parkinson's disease (PD), a disorder afflicting millions …

Behavioral Phenotyping and Pathological Indicators of Parkinson's Disease in C. elegans Models

M Maulik, S Mitra, A Bult-Ito, BE Taylor… - Frontiers in …, 2017 - frontiersin.org
Parkinson's disease (PD) is a neurodegenerative disorder with symptoms that progressively
worsen with age. Pathologically, PD is characterized by the aggregation of α-synuclein in …

[HTML][HTML] Caenorhabditis elegans in Parkinson's disease drug discovery: addressing an unmet medical need

R Nass, KM Merchant, T Ryan - Molecular interventions, 2008 - triggered.edina.clockss.org
It has been over forty years since dopamine neuron degeneration in the substantia nigra
and Lewy body formation within surviving cells were described as the pathological …

C. elegans as a model organism to investigate molecular pathways involved with Parkinson's disease

AJ Harrington, S Hamamichi… - … dynamics: an official …, 2010 - Wiley Online Library
Parkinson's disease (PD) is an age‐related movement disorder resulting, in part, from
selective loss of dopaminergic neurons. Both invertebrate and mammalian models have …

Caenorhabditis elegans as a model system for identifying effectors of α-synuclein misfolding and dopaminergic cell death associated with Parkinson's disease

AJ Harrington, AL Knight, GA Caldwell, KA Caldwell - Methods, 2011 - Elsevier
Protein misfolding and aggregation are key pathological features observed in numerous
neurodegenerative diseases, including the misfolding of α-synuclein (α-syn) in Parkinson's …

C. elegans as a genetic model system to identify Parkinson's disease-associated therapeutic targets

J Vistbakka, N VanDuyn, G Wong… - CNS & Neurological …, 2012 - ingentaconnect.com
Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor and non-
motor symptoms and the selective loss of dopaminergic neurons. The etiology of idiopathic …

Bioengineered models of Parkinson's disease using patient-derived dopaminergic neurons exhibit distinct biological profiles in a 3D microenvironment

NJ Fiore, YM Ganat, K Devkota, R Batorsky… - Cellular and Molecular …, 2022 - Springer
Abstract Three-dimensional (3D) in vitro culture systems using human induced pluripotent
stem cells (hiPSCs) are useful tools to model neurodegenerative disease biology in …